Vincent Rajkumar: Immunotherapy session makes major advances in CART, bispecifics, and ADC

Vincent Rajkumar shared the following on X:

“Immunotherapy session at the Myeloma Society Annual Meeting: we have made major advances in the last few years with CART, bispecifics, and ADC. Nikhil Munshi at Dana-Farber giving an excellent overview of Future Directions and Challenges.”

Source: Vincent Rajkumar/X

Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group.  He also chairs the Board of directors of  The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee. His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.